Form 8-K - Current report:
SEC Accession No. 0001213900-19-010601
Filing Date
2019-06-12
Accepted
2019-06-12 16:58:19
Documents
4
Period of Report
2019-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k060719_anavexlife.htm 8-K 30377
2 REGISTRATION RIGHTS AGREEMENT, DATED AS OF JUNE 7, 2019, BY AND BETWEEN THE COMP f8k060719ex4-1_anavexlife.htm EX-4.1 98001
3 PROSPECTUS SUPPLEMENT f8k060719ex5-1_anavexlife.htm EX-5.1 8338
4 PURCHASE AGREEMENT, DATED AS OF JUNE 7, 2019 BY AND BETWEEN THE COMPANY AND LINC f8k060719ex10-1_anavexlife.htm EX-10.1 243913
  Complete submission text file 0001213900-19-010601.txt   381890
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 19894139
SIC: 8731 Services-Commercial Physical & Biological Research